Drug Shortage Report for IRBESARTAN HCT

Last updated on 2018-12-29 History
Report ID 66698
Drug Identification Number 02385325
Brand name IRBESARTAN HCT
Common or Proper name IRBESARTAN HCT
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE IRBESARTAN
Strength(s) 12.5MG 300MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2018-12-07
Actual start date 2018-12-04
Estimated end date 2018-12-28
Actual end date 2018-12-28
Shortage status Resolved
Updated date 2018-12-29
Company comments
Health Canada comments
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2018-12-29 English Compare
v16 2018-12-28 French Compare
v15 2018-12-28 English Compare
v14 2018-12-17 French Compare
v13 2018-12-17 English Compare
v12 2018-12-10 French Compare
v11 2018-12-10 English Compare
v10 2018-12-08 English Compare
v9 2018-12-03 French Compare
v8 2018-12-03 English Compare
v7 2018-12-01 English Compare
v6 2018-11-26 French Compare
v5 2018-11-26 English Compare
v4 2018-11-19 French Compare
v3 2018-11-19 English Compare
v2 2018-11-12 French Compare
v1 2018-11-12 English Compare